Chile vs South Africa: Treatment success rate for patients treated for MDR-TB
Chile
64.0%
in 2022
South Africa
63.0%
in 2022
Chile rank
116th
South Africa rank
118th
Treatment success rate for patients treated for MDR-TB over time
- Chile
- South Africa
How they compare
Chile currently reports 64.0% against 63.0% in South Africa, a difference of 1.0%.
The two have swapped places 6 times across 17 shared years of data; in 2002 it was Chile ahead.
Chile ranks 116th and South Africa ranks 118th of 163 countries.
South Africa has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chile | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 31.0% | 45.2% | 14.2% | South Africa |
| 2010s | 45.2% | 53.6% | 8.4% | South Africa |
| 2020s | 59.0% | 62.3% | 3.3% | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Chile or South Africa?
- Chile, at 64.0% against 63.0% in South Africa as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Chile and South Africa?
- 1.0%, with Chile ahead.
- How many years of comparable data are there for Chile and South Africa?
- 17 years are reported by both, from 2002 to 2022.
- How do Chile and South Africa rank globally for treatment success rate for patients treated for mdr-tb?
- Chile ranks 116th and South Africa ranks 118th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.